discontinuing glp-1 Most Patients Discontinue Drugs Within a Year, Higher Dropout for Weight Loss Users Discontinuing GLP-1 Receptor Agonist Use

Type 2 diabetes mellitus is currently the only indication authorized for the prescription of exenatide, but there is a lot of data in the literature demonstrating the drugs ability to improve hepatic, adipose and whole-body insulin sensitivity while having positive effects on body weight reduction, both in diabetic and non-diabetic patients [24,25]

doi: 10.1152/ajpendo.00237.2004

Clinical studies on neuroprotection of GLP-1RAs After numerous preclinical studies have examined the neuroprotective effects of GLP-1RAs, new clinical trials have been initiated

Sanjay Gupta

Soluble intracellular adhesion molecule 1 (sICAM-1) was significantly decreased with treatment (Figure 7I)

In practical terms, that means the same thyroid pill may not behave exactly the same way once a GLP-1 medication is introduced